Johnson And Johnson Ordered To Pay $29 Million In Talc Cancer Trial

0
1010

On Wednesday, a California jury ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company’s talcum-powder-based products caused her mesothelioma.

A California jury on Wednesday ordered Johnson and Johnson to pay $29 million to a woman who alleged that asbestos in the company’s talcum-powder-based products, including Johnson’s Baby Powder, caused her mesothelioma, the latest defeat for the healthcare conglomerate which is facing thousands of similar lawsuits.

J&J said it was disappointed with the verdict and would appeal, citing “serious procedural and evidentiary errors” in the course of the trial.

The New Brunswick, New Jersey-based company denies that its talc causes cancer, saying numerous studies and tests by regulators worldwide have shown that its talc is safe and asbestos-free.

The lawsuit, brought by Terry Leavitt, was the first of more than a dozen J&J talc cases scheduled for trial in 2019. The nine-week trial began on Jan. 7 and included testimony from nearly a dozen experts on both sides.

LEAVE A REPLY